2-deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis

Nature Medicine

Volumn 20, Issue 2, 2014, Pages 215-219

  Tahara, Nobuhiro ^a   Mukherjee, Jogeshwar ^b   De Haas, Hans J ^c,d   Petrov, Artiom D ^c   Tawakol, Ahmed ^e   Haider, Nezam ^c   Tahara, Atsuko ^a   Constantinescu, Cristian C ^b   Zhou, Jun ^b   Boersma, Hendrikus H ^d   Imaizumi, Tsutomu ^a   Nakano, Masataka ^f   Finn, Aloke ^g   Fayad, Zahi ^c   Virmani, Renu ^f   Fuster, Valentin ^c,h   Bosca, Lisardo ⁱ   Narula, Jagat ^c  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f CVPATH INSTITUTE   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

ⁱ UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYSIS OF VARIANCE; ANIMALS; ATHEROSCLEROSIS; AUTORADIOGRAPHY; HUMANS; LECTINS, C-TYPE; MACROPHAGES; MANNOSE-BINDING LECTINS; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; RABBITS; RECEPTORS, CELL SURFACE; RHAMNOSE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84893755177     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3437     Document Type: Article

References (23)

1. Libby, P., Ridker, P.M. & Maseri, A. Inflammation and atherosclerosis. Circulation 105, 1135-1143 (2002).
2. Hansson, G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695 (2005).
3. Otsuka, F., Fuster, V., Narula, J. & Virmani, R. Omnipresent atherosclerotic disease: time to depart from analysis of individual vascular beds. Mt. Sinai J. Med. 79, 641-653 (2012).
4. Narula, J. et al. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J. Am. Coll. Cardiol. 61, 1041-1051 (2013).
5. Narula, J. et al. Arithmetic of vulnerable plaques for noninvasive imaging. Nat. Clin. Pract. Cardiovasc. Med. 5, S2-S10 (2008).
6. Rogers, I.S. et al. Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc. Imaging 3, 388-397 (2010).
7. Rudd, J.H. et al. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J. Am. Coll. Cardiol. 55, 2527-2535 (2010).
8. Fayad, Z.A. et al. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet 378, 1547-1559 (2011).
9. Tahara, N. et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J. Am. Coll. Cardiol. 48, 1825-1831 (2006).
10. Shepherd, P.R. & Kahn, B.B. Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus. N. Engl. J. Med. 341, 248-257 (1999).
11. Narula, J. & Strauss, H.W. The popcorn plaques. Nat. Med. 13, 532-534 (2007).
12. Villanueva, F.S. et al. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 98, 1-5 (1998).
13. Kaufmann, B.A. et al. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation 116, 276-284 (2007).
14. Hartung, D. et al. Radiolabeled monocyte chemotactic protein 1 for the detection of inflammation in experimental atherosclerosis. J. Nucl. Med. 48, 1816-1821 (2007).
15. Tsimikas, S. Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies. Am. J. Cardiol. 90, 22L-27L (2002).
16. Kolodgie, F.D. et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 108, 3134-3139 (2003).
17. Kietselaer, B.L. et al. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N. Engl. J. Med. 350, 1472-1473 (2004).
18. Bouhlel, M.A. et al. PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 6, 137-143 (2007).
19. Finn, A.V. et al. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. J. Am. Coll. Cardiol. 59, 166-177 (2012).
20. Gould, G.W., Thomas, H.M., Jess, T.J. & Bell, G.I. Expression of human glucose transporters in Xenopus oocytes: kinetic characterization and substrate specificities of the erythrocyte, liver, and brain isoforms. Biochemistry 30, 5139-5145 (1991).
21. de la Fuente, M & Hernanz, A. Enzymes of mannose metabolism in murine and human lymphocytic leukaemia. Br. J Cancer 58, 567-569 (1988).
22. Furumoto, S. et al. In vitro and in vivo characterization of 2-deoxy-2-18F-fluoro-d-mannose as a tumor-imaging agent for PET. J. Nucl. Med. 54, 1354-1361 (2013).
23. Fujimoto, S. et al. Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy. J. Nucl. Med. 54, 1354-1361 (2013).